Get started
Live feed
·
INSIDERFilingvia Quantisnow
Protalix BioTherapeutics Inc. (DE) logo

Director Boudes Pol F was granted 7,500 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataAMEX
Protalix BioTherapeutics Inc. (DE) logo
PLX
Protalix BioTherapeutics Inc. (DE)
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Follow PLXFull PLX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLX (Protalix BioTherapeutics Inc. (DE)) and more on Quantisnow.